During pregnancy, fetal DNA travels from the placenta to the mother’s blood stream and circulates along with her own DNA. VERACITY is a new generation non-invasive prenatal test that accurately measures the fetal cell-free DNA in the maternal blood to detect the presence of fetal aneuploidies and microdeletions. VERACITY has been validated for both singleton, twin and vanishing twin pregnancies.

The doctor or lab collects a blood sample from the mother’s arm and sends it to our state-of-the-art laboratories for analysis. At the laboratory, cell-free DNA is isolated from the mother’s blood and analyzed using our proprietary, new generation analytic and bioinformatic technology. Results are provided to your doctor in a few working days.

how VERAcity NIPT works



It is a test that a pregnant woman can take to check for genetic conditions of the fetus before birth.


During the first trimester, you will be offered a screening test which includes an ultrasound and a biochemical blood test. In combination with other parameters such as the mother’s age, the risk of specific genetic conditions occurring in the fetus is estimated without actually testing fetal DNA. The accuracy of this screening test is low (80 – 95%).

If the prenatal screening indicates that the fetus has a high risk of having a genetic condition, your doctor will recommend an invasive test such as amniocentesis or chorionic villus sampling. These invasive tests are highly accurate (>99%) but they have approximately 1 in 200 chance of causing a miscarriage.

Now, with VERACITY, you have the option of taking a highly accurate (>99%) and safe non-invasive prenatal test.


>99% detection rate


No risk of fetal miscarriage

Non-invasive test using a simple blood draw from the arm with no risk for the mother and the fetus


Can be done from 10 weeks Results in 4-7 working days


Validated in three multi-center studies using thousands of samples. Used by health professionals around the world.



  • Down syndrome (Trisomy 21)
  • Edwards syndrome (Trisomy 18)
  • Patau syndrome (Trisomy 13)


  • Turner syndrome (Monosomy X)
  • Triple X syndrome (Trisomy X)
  • Klinefelter syndrome (XXY)
  • Jacobs syndrome (XYY)
  • XXYY syndrome


  • DiGeorge syndrome (22q11.2)
  • 1p36 deletion syndrome
  • Smith-Magenis syndrome (17p11.2)
  • Wolf-Hirschhorn syndrome (4p16.3)


VERACITY directly tests fetal DNA, therefore, it provides the highest accuracy (>99%) in the detection of the most common fetal aneuploidies and microdeletions.

VERACITY is safe for your baby as it only requires a simple blood draw from the mother, which is not associated with the risk of miscarriage unlike invasive methods like CVS and amniocentesis.

First Trimester
Prenatal Diagnosis
Type of Test
Screening that measures likelihood of trisomies 21, 18 and 13, and X, Y aneuploidies, and four microdeletions. Screening test that measures likelihood of trisomies 21, 18, and 13. Diagnostic test to determine chromosome abnormalities.
Blood draw from 10th week of pregnancy. Blood draw and ultrasound between 11th and 14th weeks of pregnancy.

CVS: Chorionic villus sampling between 10th and 12th weeks of pregnancy.

Amniocentesis: Sampling of amniotic fluid using a needle through the abdomen between 15th and 20th weeks of pregnancy.

Safe. No risks to mother or child. Safe. No risks to mother or child. About 0.5% risk of fetal loss because of inherent invasiveness of the procedure used to obtain fetal material.
Higher than 99% for trisomy 21, 18 and 13 and several other anomalies. 80-95% for trisomy 21, 18 and 13. Higher than 99% for trisomy 21, 18 and 13 and several other anomalies.


No. All pregnant women of any age or risk category can do the VERACITY test. Although the frequency for such genetic conditions rises with the mother’s age, they can happen in any pregnancy.

Your doctor will inform you about the level of your risk.


One of the advantages of VERACITY is that you can take the test as early as the 10th week of your pregnancy and quickly obtain accurate results!




  • What is NIPT?

    NIPT is a non-invasive prenatal test which analyzes cell-free DNA in the mother’s blood to identify genetic syndromes such as trisomies and sex chromosome aneuploidies in the fetus.

  • What is VERACITY?

    VERACITY is a new generation non-invasive prenatal test that analyses cell-free DNA extracted from the mother’s blood to detect fetal genetic disorders. VERACITY can accurately detect trisomies Down syndrome, Edwards syndrome and Patau syndrome. VERACITY also tests for syndromes caused by sex chromosome aneuploidies and microdeletions as well as, provides the option to know the gender of the baby. VERACITY is a robust reliable non-invasive prenatal test that has been validated for singleton and twin pregnancies, and can also be used in IVF pregnancies.

  • Why is VERACITY important to me?

    Non-invasive prenatal testing is important because it provides a safe and accurate way to test the baby before birth for genetic disorders, the most common of which is Down syndrome. Before the introduction of this revolutionary test, the options to test for Down syndrome were either screening methods like ultrasound combined with other lab testing which have low accuracy (approximately 80-95%) or high accuracy prenatal diagnosis that uses invasive methods [e.g. amniocentesis or chorionic villi sampling (CVS)] which have 0.5% risk for miscarriage. VERACITY is a new generation non-invasive prenatal test that has significantly greater accuracy (>99%) and no risk for miscarriage.

  • What are Down syndrome, Edwards syndrome and Patau syndrome?

    Down syndrome, Edwards syndrome and Patau syndrome are genetic disorders caused by chromosomal trisomies. Down syndrome is caused by an extra copy of chromosome 21 whereas Edwards syndrome and Patau syndrome are caused by an extra copy of chromosome 18 and chromosome 13, respectively. Down syndrome is characterized by intellectual impairment and congenital abnormalities. Down syndrome occurs approximately in 1 in 700 pregnancies but is more frequent in pregnancies in women over 35. Edwards syndrome and Patau syndrome are less common occurring in 1 in 3000 and 1 in 10000 pregnancies, respectively. Edwards and Patau syndromes are characterized by severe congenital abnormalities and rarely survive past the first year of life.

    Ask your doctor about using VERACITY to detect these fetal trisomies.

  • What are sex chromosome aneuploidies?

    Sex chromosome aneuploidies are genetic diseases caused by the presence or absence of a sex chromosome. The 23rd pair of chromosomes determine the sex of an individual. Women have two X chromosomes and men have one X and one Y chromosome. There are four major sex chromosome aneuploidies:

    • Turner syndrome is characterized by the presence of a single X chromosome.
    • Triple X syndrome is characterized by the presence of three X chromosomes.
    • Klinefelter syndrome is characterized by the presence of two X chromosomes and one Y chromosome.
    • Jacob syndrome is characterized by the presence of one X chromosome and two Y chromosomes.

    Ask your doctor about using VERACITY to detect these fetal chromosomal aneuploidies.

  • What are microdeletions?

    Microdeletions are genetic conditions caused by the loss of a part of a chromosome. Microdeletions are characterized by congenital abnormalities and intellectual impairment. The severity of the symptoms varies depending on the size and location of the microdeletion. The most common microdeletion syndrome is DiGeorge syndrome which occurs approximately once in 1000 pregnancies. The prevalence of DiGeorge syndrome increases to 1 in 100 in pregnancies with major structural anomalies such as congenital heart disease.

  • Why should I choose VERACITY?

    VERACITY is a new generation non-invasive prenatal test with unparalleled accuracy. VERACITY can be done for all pregnancies after the 10th week of pregnancy and pregnancies conceived through in-vitro fertilization (IVF).

    The high accuracy of VERACITY has been demonstrated in several clinical validation studies using thousands of samples. VERACITY is fast, providing results to your doctor in a few days upon sample receipt to our laboratory. VERACITY is a safe test for both the mother and the fetus because it is performed using a simple blood draw.

  • How is the VERACITY test done?

    VERACITY requires a blood draw which is perfomed by your doctor or healthcare provider. The blood sample is sent to our laboratory and the results are provided to your doctor in few days. Your doctor or healthcare provider will discuss your VERACITY results and provide counseling.

  • How much does VERACITY cost?

    VERACITY is a new generation targeted non-invasive prenatal test. Its unique state-of-the-art design that confers unparalled accuracy also makes it a highly affordable test for the detection of fetal chromosomal aneuploidies. Please contact your healthcare provider regarding the cost of VERACITY and payment options in your country.

  • I have other questions. Where can I find additional information?

    Please contact your doctor or healthcare provider for additional information.

Other Products

NIPD Genetics - Privacy Policy

General Statement

NIPD Genetics is a leading, innovative biotechnology company that designs, develops, and provides a broad spectrum of healthcare services to its customers through its expansive portfolio of molecular and clinical laboratory tests in all disciplines.

At NIPD Genetics we are committed to protecting and respecting our customer’s privacy and personal information. Personal information or personal data means any information that identifies, relates to, describes, is capable of being associated with, or could be reasonably linked, directly or indirectly, with a particular individual, such as name, identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that individual.

NIPD Genetics collects and processes your personal information according to the General Data Protection Regulation (EU) 2016/679 and the Cypriot law providing for the protection of natural persons with regards to the processing of personal data and for the free movement of such data (L. 125(I)/2018). The following principles lie at the heart of our approach to handling personal data:

NIPD Genetics has appointed a Data Protection Officer (DPO) who is responsible for overseeing and ensuring that personal information is collected and processed in line with these principles. The contact details of the Data Protection Officer (DPO) can be found below:

Email address: dpo@nipd.com

Postal address: 31 Neas Engomis street, 2409 Engomi, Nicosia, Cyprus

Telephone number: + 357 22266888

By accessing or using our products or services, or by transmitting information to us by email or other electronic means, you accept our policies, procedures and practices described in this Privacy Policy. If you do not agree with our policies, procedures and practices as described, you can choose not to access or use our products or services or not to transmit personal information to us.

This Privacy Policy applies to NIPD Genetics facilities, its websites www.nipd.com, www.nipdlabs.com, www.nipdlabs.com.cy and their subdomains, that link to this privacy pol icy.


We collect and process several types of personal information from and about users of our websites and of our products and services, including:

Information about children

If you are under 18 years of age, do not register on our website or provide any information about yourself to us. We do not provide our products or services directly to children or proactively collect their personal information. Despite this prohibition, it is possible that we may sometimes be given information about children while handling samples from our customers in our clinical labs, or through use of our products and services by our customers and partners. If we become aware that we have inadvertently collected personal information from children under the age of 18, without parental consent, we will take the necessary steps to delete it as soon as possible in compliance with applicable laws.


Your personal information is collected by NIPD Genetics for the following purposes:

  1. To provide you with our products and services, respond to your inquiries or fulfill your requests and otherwise manage your relationship with us. The legal basis for processing is to meet the requirements of a contract, to comply with our legal obligations and/or because we have a legitimate interest in responding to requests for information about our products and services.
  2. To communicate with you about content and product offerings, newsletters and event invitations which are relevant to your interests and in line with your preferences. The legal basis for processing is the individual’s explicit consent prior to sending the information and managing individuals preferences.
  3. To process and respond to complaints. The legal basis for processing is to meet a legal obligation.
  4. To monitor and record information relating to the use of our products and services, including our website. The legal basis for processing is our legitimate interest in order to improve our products and services and our website for individuals.

To provide our products and services, NIPD Genetics may collect, receive and process biological samples to isolate and sequence DNA. NIPD Genetics may then store resulting genetic information and use genetic information to provide our products and services. In some cases, NIPD Genetics may provide interpretations of genetic information on behalf of its customers, including healthcare providers. This is only done pursuant to a written contract or a Sample Information Form with a patient’s informed consent and is subject to applicable legal and ethical safeguards.

This sensitive information described above is collected by NIPD Genetics for the following purposes:

  1. To provide support and maintenance services to customers who use our products and services – The legal basis for processing is to meet the requirements of a contract.
  2. To provide genotyping and sequencing services and analysis for our customers, including healthcare providers. The legal basis of this processing is to meet the requirements of a contract or as allowed in the Sample Information Form with a patient’s informed consent.
  3. To conduct genotyping and sequencing services and analysis for quality control, process and product development and improvements, and optimization in our labs to reflect quality improvements and advances in our technology. The legal basis for processing is the patient’s informed consent given through the Sample Information Form.

Transfer of Data

Your information, including personal data, may be transferred to - and maintained on - computers located outside your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

NIPD Genetics will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal information will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

NIPD Genetics complies with the General Data Protection Regulation and will not sell or trade your personal information.

NIPD Genetics may disclose your personal information in the good faith that such action is necessary:


Cookies are files with small amount of data which may include an anonymous unique identifiers. Cookies are sent to your browser when you visit a website and stored on your device. Tracking technologies used on the website are beacons, tags and scripts, to collect and track information and to improve and analyze our websites.

We use cookies and similar tracking technologies to track the activity on our websites and collect certain information. This includes information about the computer or device you are using, such as Internet protocol (IP) address, information about the browser type or version, the pages of our website that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our websites.

Examples of Cookies we may use:

Session Cookies. We use Session Cookies to operate our websites.

Preference Cookies. We use Preference Cookies to remember your preferences and various settings.

Security Cookies. We use Security Cookies for security purposes.

Visitor behavior cookies. To understand how visitors use and navigate the websites

Keyword cookies. To understand how visitors discover the websites.


We may use third-party Service Providers to monitor and analyze the use of our websites.

Google Analytics

Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.

You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.

For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page


We are committed to protecting the security of the information we collect, and we take reasonable physical, technical, and administrative safeguards such as data anonymization and encryption to help protect personal information from unauthorized or inappropriate access or use. It is your responsibility to protect the confidentiality of your passwords, and any other access features associated with your access or use of the website or our products and services, as well as to adhere to any applicable Terms of Use or other contract between us and you or your organization.


We may retain collected information even after you remove it from the website, our Services, or our Products, to comply with applicable law, to resolve disputes, to enforce any rights in connection with the website, our Services, or our Products, and to use as provided in this Privacy Policy, the Terms of Use, or an applicable contract between us and you or your organization. How long we retain specific personal information varies depending on the purpose for its use and we may delete or retain your personal information in accordance with applicable law.


We may employ third party companies and individuals to facilitate, maintain or operate our websites (“Service Providers”), to provide the websites on our behalf, to perform service-related services or to assist us in analyzing how our websites are used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.


Our websites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.


This Privacy Policy may be updated from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our website, prior to the change becoming effective and update the “effective date” at the bottom of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.


NIPD Genetics ensures that it can respond immediately to requests that you make for the exercise of your legal rights in accordance with data protection laws. These rights are as follows:

You also have the right to lodge a complaint at any time to the Office of the Commissioner for Personal Data Protection.

We encourage you to contact us, should you wish to practice any of your legal rights or you have any questions about this Privacy Policy, by sending an email to NIPD Genetics’ Data Protection Officer at dpo@nipd.com.

Effective date: 18/06/2021

Ok got it!